|
 |
| ORIGINAL ARTICLE |
|
| Year : 2019 | Volume
: 11
| Issue : 4 | Page : 147-152 |
|
|
Quality of life assessment in patients with androgenetic alopecia
Sanjeev Gupta, Ishan Goyal, Aneet Mahendra
Department of Dermatology and Venereolgy, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India
| Date of Web Publication | 19-Aug-2019 |
Correspondence Address:
Dr Sanjeev Gupta
Department of Dermatology and Venereolgy, Maharishi Markandeshwar Institute of Medical Sciences and Research, #B2, MM Medical College Residential Campus, Mullana, Ambala, Haryana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijt.ijt_6_19
 Abstract | | |
Background: Male-pattern alopecia (MPA) or androgenetic alopecia (AGA) is a commonly encountered dermatological condition present in males and is less common among females. Although AGA is a physiological condition, its impact on person's self-esteem is so great that it cannot be ignored. It has a significant affect over a variety of physiological and social aspects of one's life and even on the individual's overall quality of life (QOL). Aims and Objectives: The aim of this study is to study the clinical profile of 200 male patients having MPA and to access its impact on QOL using the Dermatology Life Quality Index (DLQI) and hair-specific Skindex-29. Materials and Methods: Clinical profiles of 200 patients were studied, and QOL assessment was done using the DLQI and hair-specific Skindex-29 scales. Results: Of 200 cases of MPA, majority (41.5%) of the patients belonged to the age group of 21–30 years. Smoking, alcoholism, dietary habits, nature of work, and seasonal variation did not seem to affect the incidence of MPA. Positive family history of MPA was observed in 50% of patients. A mean DLQI score of 13.52 was recorded in the study. The main affected parameter was personal relations with mean score of 2.3. Maximum number of patients had DLQI score between 11 and 20. MPA was observed in 50% of patients. In the study, the mean hair-specific Skindex-29 score was found to be 75.62. The different subscale parameters in Skindex-29 were symptoms, functions, emotions; with respective score of 22.1 ± 5.025, 25.89 ± 4.814, and 27.73 ± 5.942. The major subscales affected were symptoms with a mean score of 3.14. Both hair-specific Skindex-29 and DLQI had a significant correlation, thereby suggesting that AGA significantly affects patient's QOL. Conclusion: AGA harmfully affected the patient's QOL which warns the physicians to pay more attention to QOL impairment in patients of AGA for the better understanding of the disease burden on individual patients.
Keywords: Androgenetic alopecia, India, male, observational study
How to cite this article:
Gupta S, Goyal I, Mahendra A. Quality of life assessment in patients with androgenetic alopecia. Int J Trichol 2019;11:147-52 |
| Introduction | |  |
Hair is one of the defining characteristics of mammals. All through the ages, it has sociological and psychological importance in making appearance and personality of a person. The cultural origin of humankind is reflected in different hair styles and different hair-shaving patterns. It also reflects the person's status and his distinct personality. Due to hair hype by public and media advertisement, hair excess or loss is socially and cosmetically unacceptable as in hirsutism and alopecia. The genetically determined progressive process that causes a gradual conversion of terminal hair into vellus hair is known as androgenetic alopecia (AGA), which is the most common type of hair loss affecting over 70% of adult males and 50% of women.[1] AGA is a benign condition and can have significant psychological impact on a person and involves both hormonal and genetic factors. Some studies conducted in the past also signify that AGA can have psychosocial complications, including depression, low self-esteem altered self-image, and less frequent and enjoyable social engagements. In patients with AGA due to continuous disease progression, quality of life (QOL) gets impaired. Therefore, treatment and counseling is very important in these cases. There are not many studies on the QOL in patients of AGA. Therefore, this study was carried out to know the psychosocial aspects affecting the patient's life due to disease progression and its prospects in the future population.
| Materials and Methods | | |
This prospective study was conducted in the outpatient department of dermatology in a tertiary care center in North India. A total of 200 male patients in the age group of 18–60 years with AGA Grade I–VII of the Hamilton–Norwood classification were enrolled in the study. The participation was totally voluntary, and informed consent was obtained from all the patients willing to participate in the study. Patients with any other dermatological disease were excluded from the study. The study had ethical approval from the institute.
All the demographic parameters including age, duration of alopecia, detailed family history, occupation, education, marital status, and history of onset were recorded in the pro forma designed. All patients were classified according to BG Prasad classification for socioeconomic status. QOL in all patients was assessed using the Dermatology Life Quality Index (DLQI) scale and the hair-specific Skindex-29 scale. The DLQI questionnaire was used to know the hair and scalp problems for the past week. The DLQI score consisted of maximum of 3 and minimum of 0 values against a total of 30 score for each patient. The Hairdex scale consisted of three subscales, i.e., emotion, function, and symptom. The pro forma consisted of 29 questionnaires with a maximum score of 5 and minimum score of 1 for each questionnaire. The total minimum score was 29 and maximum score was 145 for each patient. Each score was recorded on the pro forma and the total score was calculated.
| Results | | |
The minimum age group belong to 18 years and maximum age group to 60 years in all 200 patients of AGA. [Table 1] shows the maximum number of patients, i.e., 44.5% belong to the age group of 21–30 years. The mean age was found to be 32 years. Distribution of the study patients was done according to socioeconomic status based on the modified BG Prasad classification.
[Table 1] also shows the distribution of patients according to the socioeconomic status. Maximum (76) number of patients belonged to middle class (Class III). Most (53%) of the patients in total were unmarried. Majority (61%) of the patients affected were from urban background.
The total duration of hair fall in 50% of patients was between 0 and 5 years. Most of the study patients were from younger age group and, therefore, had a short duration of history of hair fall. The mean duration of disease was 5.8 years of age.
[Table 1] also shows the distribution of educational status. Majority (107) of the patients were graduates. They were followed by 37 patients who completed their 10th standard and 32 patients who studied till the 12th standard. Only 12 patients were postgraduates. Five patients studied till the 8th standard and two patients were illiterate. In the total study population, most (49.5%) of the patients were engaged in indoor work, 104 patients were vegetarian, 130 patients were nonalcoholics, and 145 patients were nonsmokers. Majority (92.5%) of the patients did not have any associated disease. Only 7% of patients had a history of diabetes or hypertension. Maximum (77%) number of patients sought medical advice for the first time for male-pattern alopecia (MPA). Only nine patients sought minoxidil as a treatment option.
[Table 2] shows the distribution of study patients based on the Hamilton–Norwood scale. The total patients with Grade III presentation were 60 which were the most affected group, followed by Grade II and IIA which were 22 patients in each group. Grade VII was the least affected group among the others with only four patients. The age group of 21–30 years had most number of patients with maximum patients belonging to Grade IIA.
[Table 3] shows that the total mean of DLQI score was 13.52 with the standard deviation of 3.15. The mean percentage obtained in the present study was 45.1%. The total mean of Hairdex-29 score was 75.62 with a standard deviation of 13.78. The mean percentage obtained was 52.2%. The different subscale parameters in Skindex-29 were symptoms, functions, emotions; with respective score of 22.1 ± 5.025, 25.89 ± 4.814, and 27.73 ± 5.942. The most common presentation in symptom subscale was “water bothers my scalp” with a mean score of 3.265, whereas the least effected symptom was”my scalp itches.” The highest affected emotion questionnaire was “I am humiliated by my alopecia” with a mean of 3.045. In function subscale, the highest mean (2.58) was of decreased desire to be with people. | Table 3: Scoring according to dermatology life quality index and hair-specific Skindex-29 scales
Click here to view |
| Discussion | | |
In today's world, dermatologists treat patients with a wide range of diseases (many of them severe or life-threatening) that it may be hard to take the effect of male-pattern hair loss (also known as AGA) seriously on the QOL of those affected by it.[2]
It should be specified that hair growth and hair style are important elements of an individual's identity: hair strongly influences whether or not a person is seen as physically attractive,[3] and there are consistent advantages of being perceived as attractive,[4] such as better personal relations, better emotional and psychological strength, and priority in employment practices. Girman et al.[5] showed that men with greater hair loss had more concern about getting older, perceived noticeability to others and greater dissatisfaction with their hair appearance than men with less hair loss.
Given the psychological and symbolic importance of hair, it is not surprising that hair loss may have a potentially adverse impact on a person's QOL. Unfortunately, this impact is often ignored by those not affected by it. It has been proven difficult to convince the public and medical practitioners that male-pattern hair loss has any significant effect on QOL. Even the history of the treatment of AGA has more than its fair share of “trichoquackery,” and medical practitioners are reluctant about any claims to treat AGA, and thus, QOL is totally ignored.[1]
Thus, this study was conducted to assess the effects on QOL of AGA patients, by DLQI and Skindex-29 scales. We chose two scales to better out the assessment process of QOL owing to the importance of knowing all the aspects that are affected after hair loss: emotional, functional, and symptomatic.
The current study found that the effect of AGA on QOL was comparable to other studies.[5],[6],[7] Consistent with previous findings,[5],[6] young adults were more affected in our study. Although negative effects due to hair loss were reported across all age groups, they were more apparent in younger men.
Goldberg–Huxley suggested that the group which suffers most in terms of QOL are those who are under specialist treatment and consult their general practitioner, as compared to those who “cope” with their disease.[8] This is illustrated in our study where >50% of participants reported a diagnosis more than 5 years previously and yet were still seeking medical consultation, suggestive of the continuous psychological impact of alopecia and its role in shaping identity.
Most of the patients were from middle class, urban settled, and unmarried. Stressful environment – pertaining to the urban standards of living in a nuclear family – and anxiety of losing hair are the key triggering factors in the progression of AGA. These changes were more perceived in younger population with an increase in stressful conditions in an urban setup.
In line with the previous findings regarding the psychological consequences of alopecia,[9],[10],[11] patients reported increased symptoms such as scalp irritation, always bothered, burning, and itchy sensation. Patients experienced loss of desire to meet people and preferred staying at home and did not even want to interact with close ones. Emotionally, patients experienced embarrassment, humiliation, and depression due to MPHL (Male pattern hair loss) which was in accordance with Wells et al.[12] Alfonso et al.[13] also reported negative effects on social life and feeling of depression which were similar to our study.
Clinical symptoms, functional behavior, and emotional stability in addition to anxiety and worry about hair loss all affect the QOL of an individual. Patients showed deterioration at all levels. The mean DLQI score was high and comparable with Tahir et al.[14] The impaired DLQI score suggested that AGA has a negative impact over the individual's life. The altered feelings due to acceptance of hair loss, thereby reducing daily leisure and outdoor activities to avoid negative emotions from their surroundings and decreasing social outgoings, led to a cycle of depression and anxiety. The increased stress created due to all the factors forced patients to opt for alternate means such as wearing hats or wigs to prevent psychosocial discomfort. Such means increase the financial pressure and decrease the self-esteem of the patients.
The symptom scale was most deranged in our study out of symptoms, functions, and emotions in hair-specific Skindex-29, accounting for more focus of the patients on the itching and burning scalp before accepting and knowing the fact that it is a continuing progressive condition termed AGA. Most of the patients in our study had Grade III baldness which may be considered a normal process in today's lifestyle, limiting their response in terms of emotional and functional setbacks. The emotional and functional side effects of AGA arise after the partial or complete acceptance of the condition and understanding the fact that this may progress to complete baldness. The most important illness perceptions were illness identity, illness consequences and a strong emotional response to the condition. Both identity and consequences have consistently been shown to be strong predictors of outcomes in other studies with chronic illness,[15],[16],[17] and emotional representations are emerging as an important predictor of QOL.[18],[19]
Accounting for the unpredictable condition, uncertain etiology, and limited treatment, patients later felt helpless. The current study suggests that practitioners need to move the focus away from symptoms and to help people to deal with their emotional responses to AGA. In addition, other studies show that people with high-grade alopecia want greater attention given to psychological issues arising from the condition [Table 4].[9],[14],[20],[21],[22],[23],[24] Thus, it is important that practitioners recognize the long-term psychological impact of alopecia such as depression and anxiety and start addressing patients' perceptions of their illness and concerns about the future. | Table 4: The demographic parameters present in different studies of androgenetic alopecia
Click here to view |
Dermatologists can help in better emotional adjustment by illness coherence, proper diagnosis, and suggestions with newer treatment options and convincing them to judiciously continue treatment.
Recent advancements have led to the introduction of DNA testing of androgen receptor gene to diagnose the condition and relate the future probability of baldness and relative prognosis. The newer treatment options such as platelet-rich plasma (PRP) therapy and low-level laser light therapy (LLLT), in addition to standard drug treatments such as minoxidil and finasteride, have opened gates for better control of AGA. However, the limited treatment options can only delay the process but cannot reverse it completely. PRP and LLLT therapy can help in increasing 30% thickness of hair if continued regularly, but the effects reverse if discontinued. Studies are needed to assess whether such interventions are effective in improving patient outcomes and reducing psychological disorders among those with alopecia.
Various limitations of the study should, however, be considered when evaluating the findings. Despite the strong relationships between illness and QOL, the use of a cross-sectional design restricts the causality of these relationships. Prospective longitudinal studies are needed to assess how people's perception of alopecia is affected with time. Long-term studies are needed to note the treatment outcomes particularly related to hair loss itself and psychological support to overcome the stress of AGA. It would be interesting to examine psychological response both during periods of hair loss and during periods of remission.
| Conclusion | | |
AGA is a common dermatological condition, with potentially adverse psychosocial sequelae. Research confirms a negative moderate effect of visible hair loss on symptomatic, emotional, social, and psychological state. More importantly, AGA is typically experienced as a moderately stressful condition that diminishes body image satisfaction. The medical practitioners can play a role in improvement of patients' QOL, by recognizing and addressing the psychological impact of alopecia. However, further research will be needed to know the QOL improvement with the newer behavioral PRP and LLLT therapies.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Price VH. Androgenetic alopecia in women. J Investig Dermatol Symp Proc 2003;8:24-7.  |
| 2. | Passchier J. Quality of life issues in male pattern hair loss. Dermatology 1998;197:217-8. |
| 3. | Terry RL, Davis JS. Components of facial attractiveness. Percept Mot Skills 1976;42:918. |
| 4. | Cash TF. The psychology of physical appearance: Aesthetics, attributes and images. In: Cash TF, Pruzinsky T, editors. Body Images: Development, Deviance and Change. New York, Guilford; 1990. p. 51-79. |
| 5. | Girman CJ, Rhodes T, Lilly FR, Guo SS, Siervogel RM, Patrick DL, et al. Effects of self-perceived hair loss in a community sample of men. Dermatology 1998;197:223-9. |
| 6. | Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992;26:926-31. |
| 7. | van der Donk J, Passchier J, Knegt-Junk C, van der Wegen-Keijser MH, Nieboer C, Stolz E, et al. Psychological characteristics of women with androgenetic alopecia: A controlled study. Br J Dermatol 1991;125:248-52. |
| 8. | Goldberg D, Huxley P. Mental illness in the Community. London: Fairstock Publications; 1988. |
| 9. | Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2001;15:137-9. |
| 10. | Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994;33:849-50. |
| 11. | Camacho FM, García-Hernández M. Psychological features of androgenetic alopecia. J Eur Acad Dermatol Venereol 2002;16:476-80. |
| 12. | Wells PA, Willmoth T, Russell RJ. Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol 1995;86(Pt 3):337-44. |
| 13. | Alfonso M, Richter-Appelt H, Tosti A, Viera MS, García M. The psychosocial impact of hair loss among men: A multinational European study. Curr Med Res Opin 2005;21:1829-36. |
| 14. | Tahir K, Aman S, Naddem M, Kazmi AH. Quality of life in patients with androgenetic alopecia. Ann King Edward Med Univ 2013;19:150-4. |
| 15. | Hagger M, Orbell S. A meta-analytic review of the common-sense model of illness representations. Psychol Health 2003;18:141-84. |
| 16. | Scharloo M, Kaptein AA, Weinman J, Hazes JM, Willems LN, Bergman W, et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res 1998;44:573-85. |
| 17. | Heijmans M. The role of patients' illness representations in coping and functioning with Addison's disease. Br J Health Psychol 1999;4:137-49. |
| 18. | Gray E, Rutter D. Illness representations in young people with chronic fatigue syndrome. Psychol Health 2007;22:159-74. |
| 19. | Jessop D, Rutter D. Adherence to asthma medication: The role of illness representations. Psychol Health 2003;18:595-612. |
| 20. | Hunt N, McHale S. Reported experiences of persons with alopecia areata. J Loss Trauma 2005;10:33-50. |
| 21. | Han SH, Byun JW, Lee WS, Kang H, Kye YC, Kim KH, et al. Quality of life assessment in male patients with androgenetic alopecia: Result of a prospective, multicenter study. Ann Dermatol 2012;24:311-8. |
| 22. | Bade R, Bhosle D, Bhagat A, Shaikh H, Sayyed A, Shaikh A. Impact of androgenic alopecia on the quality of life in male subjects: Results of an observational study from tertiary care hospital. J Med Sci Clin Res 2016;4:12900-7. |
| 23. | Sawant N, Chikhalkar S, Mehta V, Ravi M, Madke B, Khopkar U. Androgenetic alopecia: Quality-of-life and associated lifestyle patterns. Int J Trichology 2010;2:81-5. |
| 24. | Sung-Hyub Han. Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study. Ann Dermatol 2012;24:311-8. |
[Table 1], [Table 2], [Table 3], [Table 4]
| This article has been cited by | | 1 |
Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study |
|
| Moussa Laanani, Alain Weill, Fabrice Jollant, Mahmoud Zureik, Rosemary Dray-Spira | | Scientific Reports. 2023; 13(1) | | [Pubmed] | [DOI] | | | 2 |
Iontophoresis in dermal delivery: A review of applications in dermato-cosmetic and aesthetic sciences |
|
| Aikaterini Liatsopoulou, Athanasia Varvaresou, Fotini Mellou, Evangelia Protopapa | | International Journal of Cosmetic Science. 2023; | | [Pubmed] | [DOI] | | | 3 |
Assessment of quality of life and
self-esteem
in male patients with androgenetic alopecia before and after hair transplantation
|
|
| Mohammad Ali Nilforoushzadeh, Maryam Golparvaran, Mir Saeed Yekaninejad | | Journal of Cosmetic Dermatology. 2023; | | [Pubmed] | [DOI] | | | 4 |
Evaluation of Anxiety and Depression in Patients with Androgenetic Alopecia in Shanghai: A Cross-Sectional Study |
|
| Linli Yu, SathishKumar Moorthy, Lin Peng, Liangliang Shen, Yu Han, Zikai Zhang, Yanqiao Li, Xin Huang, Jung Eun Kim | | Dermatologic Therapy. 2023; 2023: 1 | | [Pubmed] | [DOI] | | | 5 |
Systematic Review of Psychological Interventions for Quality of Life, Mental Health, and Hair Growth in Alopecia Areata and Scarring Alopecia |
|
| Jessica Maloh, Tess Engel, Nicole Natarelli, Yvonne Nong, Alina Zufall, Raja K. Sivamani | | Journal of Clinical Medicine. 2023; 12(3): 964 | | [Pubmed] | [DOI] | | | 6 |
Positioning of low alcohol or alcohol-free minoxidil formulation for the management of androgenetic alopecia: Indian perspective |
|
| Satish Udare, Anita Baruah, Anurag Mathur, TR Dayananda, Kapil Jain, ManasRanjan Puhan, Pawan Bajaj, Richa Sharma, SanjayRamanbhai Gamit, V Ramesh, V Venugopal, Vignesh Karthik, MonilYogesh Neena Gala, Snehal Muchhala, Amey Mane | | International Journal of Trichology. 2023; 15(1): 13 | | [Pubmed] | [DOI] | | | 7 |
The Association of Depression, Loneliness, and Internet Addiction Levels in Male Bachelor of Medicine, Bachelor of Surgery (MBBS) Students With Androgenetic Alopecia Male Pattern Baldness in a Medical College in Kolar, India |
|
| Harish Prasanna, Rajashekar T S, Suresh Kumar K, Athish KK, Madhu Kiran, Meghana Reddy | | Cureus. 2023; | | [Pubmed] | [DOI] | | | 8 |
Androgenetic alopecia: What impact does it have on the quality of Life? |
|
| AdemolaOlusegun Enitan, OlayinkaAbimbola Olasode, OlaniyiEmmanuel Onayemi, AtinukeArinola Ajani, OlumayowaAbimbola Oninla, FataiOlatunde Olanrewaju, MufutauMuphy Oripelaye | | Nigerian Journal of Medicine. 2022; 31(4): 455 | | [Pubmed] | [DOI] | | | 9 |
Pumpkin Seed Oil-Loaded Niosomes for Topical Application: 5a-Reductase Inhibitory, Anti-Inflammatory, and In Vivo Anti-Hair Loss Effects |
|
| Veerawat Teeranachaideekul, Warisara Parichatikanond, Varaporn Buraphacheep Junyaprasert, Boontida Morakul | | Pharmaceuticals. 2022; 15(8): 930 | | [Pubmed] | [DOI] | | | 10 |
Exploiting Recent Trends in the Treatment of Androgenic Alopecia through Topical Nanocarriers of Minoxidil |
|
| Khushbakht Saleem, Bazla Siddiqui, Asim .ur.Rehman, Malik Mumtaz Taqi, Naveed Ahmed | | AAPS PharmSciTech. 2022; 23(8) | | [Pubmed] | [DOI] | | | 11 |
Quality of Life and Its Association with Androgenetic Alopecia Patients in Shanghai: A Cross-Sectional Study |
|
| SathishKumar Moorthy, Linli Yu, Lin Peng, Liangliang Shen, Yu Han, Zikai Zhang, Yanqiao Li, Xin Huang | | Clinical, Cosmetic and Investigational Dermatology. 2022; Volume 15: 2883 | | [Pubmed] | [DOI] | | | 12 |
Association between Androgenetic Alopecia and Psychosocial Disease Burden: A Cross-Sectional Survey among Polish Men |
|
| Roksana Adamowicz, Piotr Zalecki, Anna Dukiel, Danuta Nowicka, Craig G. Burkhart | | Dermatology Research and Practice. 2022; 2022: 1 | | [Pubmed] | [DOI] | | | 13 |
The psychological consequences of androgenetic alopecia: A systematic review |
|
| Erica L. Aukerman, Mohammad Jafferany | | Journal of Cosmetic Dermatology. 2022; | | [Pubmed] | [DOI] | | | 14 |
Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional-comparative study |
|
| Amr M. Ammar, Ahmed R. Elshahid, Hamdy A. Abdel-Dayem, Ahmed A. Mohamed, Mohamed L. Elsaie | | Journal of Cosmetic Dermatology. 2022; | | [Pubmed] | [DOI] | | | 15 |
An assessment for measuring loneliness, anxiety, and depression in male patients with androgenetic alopecia undergoing hair transplantation surgery: A before-after study |
|
| Mohammad Ali Nilforoushzadeh, Maryam Golparvaran | | Journal of Cosmetic Dermatology. 2022; | | [Pubmed] | [DOI] | | | 16 |
Insights into male androgenetic alopecia using comparative transcriptome profiling: hypoxia-inducible factor-1 and Wnt/ß-catenin signalling pathways |
|
| Qingmei Liu, Yulong Tang, Yan Huang, Ji’an Wang, Kai Yang, Yuting Zhang, Weilin Pu, Jing Liu, Xiangguang Shi, Yanyun Ma, Chunya Ni, Yue Zhang, Yifei Zhu, Haiyang Li, Jiucun Wang, Jinran Lin, Wenyu Wu | | British Journal of Dermatology. 2022; | | [Pubmed] | [DOI] | | | 17 |
The iceberg phenomenon of alopecia associated public health ramifications on the quality of life among adults in India |
|
| Vaibhav Kumar, Debraj Shome, Swarali Y. Atre, Aradhana Nagarsekar, Ridhima Gaunkar, Rinky Kapoor, Komal Doshi | | Dermatological Reviews. 2022; | | [Pubmed] | [DOI] | | | 18 |
Efficacy assessment for low-level laser therapy in the treatment of androgenetic alopecia: a real-world study on 1383 patients |
|
| Jun Qiu, Yanhua Yi, Linlang Jiang, Yong Miao, James Jia, Jian Zou, Zhiqi Hu | | Lasers in Medical Science. 2022; | | [Pubmed] | [DOI] | | | 19 |
Sleep quality in men with androgenetic alopecia |
|
| Somprasong Liamsombut, Cherrin Pomsoong, Chaninan Kositkuljorn, Kanchana Leerunyakul, Visasiri Tantrakul, Poonkiat Suchonwanit | | Sleep and Breathing. 2022; | | [Pubmed] | [DOI] | | | 20 |
The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata |
|
| Kavita Gandhi, Morgan E. Shy, Markqayne Ray, Moshe Fridman, Shailja Vaghela, Arash Mostaghimi | | Dermatology and Therapy. 2022; | | [Pubmed] | [DOI] | | | 21 |
Clinical Patterns of Hair Loss in Men |
|
| Natalie Kash, Matt Leavitt, Adam Leavitt, Spencer D. Hawkins, Rahil B. Roopani | | Dermatologic Clinics. 2021; 39(3): 361 | | [Pubmed] | [DOI] | | | 22 |
Quality of life in young men with androgenetic alopecia: A mixed methods study |
|
| Josip Razum, Tena Vukasovic Hlupic | | Journal of Cosmetic Dermatology. 2021; | | [Pubmed] | [DOI] | | | 23 |
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia |
|
| Chun-Hsien Huang, Yun Fu, Ching-Chi Chi | | JAMA Dermatology. 2021; 157(8): 963 | | [Pubmed] | [DOI] | | | 24 |
Association between psychosocial distress, sexual disorders, self-esteem and quality of life with male androgenetic alopecia: a population-based study with men at age 46 |
|
| Suvi-Päivikki Sinikumpu, Jari Jokelainen, Juha Auvinen, Markku Timonen, Laura Huilaja | | BMJ Open. 2021; 11(12): e049855 | | [Pubmed] | [DOI] | | | 25 |
Measuring Patient Quality of Life Following Treatment for Alopecia |
|
| Kunlawat Thadanipon, Poonkiat Suchonwanit | | Patient Preference and Adherence. 2021; Volume 15: 1601 | | [Pubmed] | [DOI] | | | 26 |
Effects on Steroid 5-Alpha Reductase Gene Expression of Thai Rice Bran Extracts and Molecular Dynamics Study on SRD5A2 |
|
| Chiranan Khantham, Wipawadee Yooin, Korawan Sringarm, Sarana Rose Sommano, Supat Jiranusornkul, Francisco David Carmona, Wutigri Nimlamool, Pensak Jantrawut, Pornchai Rachtanapun, Warintorn Ruksiriwanich | | Biology. 2021; 10(4): 319 | | [Pubmed] | [DOI] | | | 27 |
Psychology’s medicalization of male baldness |
|
| Glen S Jankowski, Hannah Frith | | Journal of Health Psychology. 2021; : 1359105321 | | [Pubmed] | [DOI] | | | 28 |
Cross sectional quality of life assessment in patients with androgenetic alopecia |
|
| Lotfy T. Elsaie, Ahmed R. Elshahid, Hitham M. Hasan, Fatma Al Zahraa M. Soultan, Mohammad Jafferany, Mohamed L. Elsaie | | Dermatologic Therapy. 2020; 33(4) | | [Pubmed] | [DOI] | | | 29 |
Patient characteristics, expectations and willingness to pay for hair loss therapies: A survey of 1561 participants at a tertiary dermatological referral centre in Singapore |
|
| Ellie Ci-En Choi, Xiahong Zhao, Joyce Siong-See Lee, Etienne CE Wang | | Australasian Journal of Dermatology. 2020; 61(4) | | [Pubmed] | [DOI] | |
|
 |
|
|
|
